Core Viewpoint - As of August 26, 2025, the stock price of Kangtong Medical (301515) closed at 23.35 yuan, experiencing a decline of 0.34% with a trading volume of 1.93 million hands and a transaction amount of 45.37 million yuan [1] Financial Performance - The company's main revenue for Q1 2025 was 24.29 million yuan, a year-on-year decrease of 68.09% - The net profit attributable to the parent company was 1.58 million yuan, down 85.25% year-on-year - The net profit after deducting non-recurring gains and losses was 1.41 million yuan, a decline of 86.46% year-on-year - The debt ratio stood at 36.26%, with financial expenses recorded at -515,200 yuan and a gross profit margin of 36.15% [3] Market Position - Kangtong Medical's total market value is 2.335 billion yuan, significantly lower than the industry average of 12.328 billion yuan, ranking 118 out of 123 in the medical device industry - The company's net assets are 1.248 billion yuan, compared to the industry average of 3.881 billion yuan, also ranking 98 out of 123 - The price-to-earnings ratio (P/E) is 369.71, much higher than the industry average of 65.92, ranking 93 out of 123 - The price-to-book ratio (P/B) is 1.89, lower than the industry average of 4.03, ranking 31 out of 123 - The gross margin is 36.15%, compared to the industry average of 51.3%, ranking 92 out of 123 - The net margin is 6.5%, lower than the industry average of 11.2%, ranking 78 out of 123 - The return on equity (ROE) is 0.12%, significantly below the industry average of 1.92%, ranking 96 out of 123 [3]
股票行情快报：港通医疗（301515）8月26日主力资金净买入144.45万元